Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Wet age-related macular degeneration

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Modes of action of selected treatments for wet age-related macular degeneration in clinical development.
Figure 2: Projected growth of the wet age-related macular degeneration market.

References

  1. Schachat, A. P. New treatments for age-related macular degeneration. Ophthalmology 112, 531–532 (2005).

    Article  Google Scholar 

  2. Karagiannis, T. C. & El-Osta, A. RNA interference and potential therapeutic applications of short interfering RNAs. Cancer Gene Ther. 13 May 2005 [Epub ahead of print].

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melnikova, I. Wet age-related macular degeneration. Nat Rev Drug Discov 4, 711–712 (2005). https://doi.org/10.1038/nrd1827

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1827

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing